HP
HealthInvest Partners Portfolio holdings
AUM $234M
1-Year Return
10.88%
This Quarter Return
+3.64%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$62.8M
AUM Growth
-$8.16M
(-11%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-20.63%
Top 10 Holdings %
Top 10 Hldgs %
97.34%
Holding
18
New
5
Increased
1
Reduced
6
Closed
6
Top Buys
| 1 |
Biogen
BIIB
|
+$5.9M |
| 2 |
Gilead Sciences
GILD
|
+$5.83M |
| 3 |
Cigna
CI
|
+$5.75M |
| 4 |
Utah Medical Products
UTMD
|
+$1.44M |
| 5 |
Zevra Therapeutics
ZVRA
|
+$1.28M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$6.5M |
| 2 |
Cencora
COR
|
+$6.38M |
| 3 |
Harmony Biosciences
HRMY
|
+$3.65M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
+$3.24M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$3.17M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
McKesson
MCK
$87.4B
| $9.18M | 14.62% |
30,000
-4,000
| -12% | -$1.22M |
|
2
Ironwood Pharmaceuticals
IRWD
$208M
| $8.93M | 14.22% |
710,000
-20,000
| -3% | -$252K |
|
3
Bristol-Myers Squibb
BMY
$94.3B
| $5.99M | 9.53% |
82,000
-18,000
| -18% | -$1.31M |
|
|
4
Biogen
BIIB
$21B
| $5.9M | 9.39% |
+28,000
| New | +$5.9M |
|
|
5
Harmony Biosciences
HRMY
$1.87B
| $5.84M | 9.3% |
120,000
-75,000
| -38% | -$3.65M |
|
|
6
Gilead Sciences
GILD
$140B
| $5.83M | 9.28% |
+98,000
| New | +$5.83M |
|
|
7
Cigna
CI
$79.3B
| $5.75M | 9.16% |
+24,000
| New | +$5.75M |
|
8
Cardinal Health
CAH
$35.9B
| $5.67M | 9.03% |
100,000
-25,000
| -20% | -$1.42M |
|
|
9
Utah Medical Products
UTMD
$200M
| $5.03M | 8.01% |
56,000
+16,000
| +40% | +$1.44M |
|
|
LJPC
10
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.02M | 4.81% |
707,000
-123,000
| -15% | -$525K |
|
|
11
Zevra Therapeutics
ZVRA
$406M
| $1.28M | 2.04% |
+255,000
| New | +$1.28M |
|
|
OPNT
12
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $386K | 0.61% |
+18,000
| New | +$386K |
|
|
13
AbbVie
ABBV
$384B
| – | – |
-48,000
| Closed | -$6.5M |
|
|
14
Cencora
COR
$56.5B
| – | – |
-48,000
| Closed | -$6.38M |
|
15
Rigel Pharmaceuticals
RIGL
$669M
| – | – |
-109,000
| Closed | -$2.89M |
|
|
ICPT
16
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-183,000
| Closed | -$2.98M |
|
|
LCI
17
DELISTED
Lannett Company, Inc.
LCI
| – | – |
-500,000
| Closed | -$3.24M |
|
|
ZGNX
18
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-195,000
| Closed | -$3.17M |
|